ELAN - CIK 0001739104
Elanco Animal Health Inc trades as ELAN and has a market capitalization of $11.42 B, making it the #867 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $4.71B, up 6.2% from the prior year and net income of -$232.00M. This page tracks Elanco Animal Health Inc through 976 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Elanco Animal Health Inc's revenue grew from $2.91B to $4.71B, a compound annual growth rate of 5.5%. Net profit margin compressed from -1.6% to -4.9% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-26 |
INDIANAPOLIS , April 16, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN ) will announce its first quarter 2026 financial results on Wednesday, May 6, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance.
INDIANAPOLIS, Jan. 22, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN ) will announce its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance.
INDIANAPOLIS , Jan. 6, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN ) will participate in the 44 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026. Jeff Simmons, president and CEO, and Bob VanHimbergen, executive vice president and CFO, will represent the company and respond to questions from analysts at 3:45 p.m. PST (6:45 PM EST).
The largest companies sharing Elanco Animal Health Inc's SEC industry classification (pharmaceutical preparations).
Elanco Animal Health Inc (ELAN) has a market capitalization of $11.42 B as of 2026-06-10, ranking #867 among US-listed companies.
Elanco Animal Health Inc reported revenue of $4.71B for fiscal year 2025, an increase of 6.2% year over year.
In its latest fiscal year Elanco Animal Health Inc reported a net loss of $232.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.